NLS Pharmaceutics (NCEL) P/E (2021 - 2026)
NLS Pharmaceutics (NCEL) P/E from Jan 29, 2021 to Jul 20, 2026. The TTM NLS Pharmaceutics (NCEL) P/E is -2.29. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of NLS Pharmaceutics (NCEL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.29 | +108.95% |
| 2025 | -1.10 | -73.52% |
| 2024 | -4.15 | -91.06% |
| 2023 | -46.38 | -33.80% |
| 2022 | -70.05 | +16.22% |
| 2021 | -60.28 | N/A |
Comparison NLS Pharmaceutics (NCEL) P/E with competitors
NLS Pharmaceutics (NCEL) P/E is -2.29.